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Two single site substitutions (E47s-tQ and Hss9 +F) were introduced into the C-terminal RNase H domain of HIV-l reverse transcriptase. These 
mutant proteins were expressed in Escherichiu co/i and purified by Nt “+-nitrilotriacetic acid affinity chromatography. Both enzymes are clearly 
defective in RNase H function, but exhibit wild type reverse transcriptase activity. 
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1. INTRODUCTION counterpart [ 1 I]. RNase H might therefore be a promis- 
ing target for a new class of antiviral drugs. 
Retroviruses contain an RNase H activity which 
cleaves the RNA within a RNA-DNA hybrid [l-3]. This 
activity is an integral part of the reverse transcriptase 
(RT) enzyme [4,5]. The RNase H domain of retroviral 
RTs resides in the C-terminal part of the protein which 
displays partial homology with Escherichia coli RNase 
H. This functional assignment [6] was verified by pro- 
teolytic fragmentation [7], deletion studies [8,9], linker 
insertion [lo] and site-directed mutagenesis [ 111. 
Such an approach requires a more profound insight 
into the structure and function of HIV-l RT-RNase H. 
To this end, we have constructed mutant enzymes car- 
rying amino acid exchanges at conserved positions with- 
in the RNase H domain. With the help of these subtly 
altered proteins, we have been able to pinpoint residues 
important for RT-RNase H function. 
In the course of retroviral replication, the RT- 
associated RNase H activity probably serves a variety of 
functions. Synthesis of minus strand cDNA (the first in- 
termediate in retrotranscription of viral genomic 
RNAs) initiates from a tRNA primer hybridized to a 
complementary sequence downstream of the 5 ’ LTR 
denoted the primer binding site (pbs). The template 
RNA which has been copied into cDNA is then very 
likely cleaved by RNase H to allow base pairing of the 
second template RNA and elongation of the minus 
strand cDNA [12]. RNase H digestion of the resulting 
DNA-RNA hybrid generates polypurine RNA frag- 
ments with free 3 ’ hydroxyl ends which can serve as 
primers for the synthesis of plus strand cDNA [13,14]. 
Finally, the tRNA primer has to be removed by RNase 
H in order to allow completion of plus strand cDNA 
synthesis [ 151. At least in the case of Moloney Murine 
Leukemia Virus (MMuLV), this RT-associated RNase 
H activity is indispensable for viral replication and loss 
of function cannot be complemented by a cellular 
2. MATERIALS AND METHODS 
2.1. Cloning and mutagenesis of RT-RNase H 
The complete HIV-l RT-fragment (1680 bp) was excised from vec- 
tor p6HRT [16] with BarnHI and Hind111 and ligated into the poly- 
linker of M13mp18. Mutagenesis was performed using the Amersham 
Ml3 mutagenesis kit [17]. The mutated DNAs were sequenced, cloned 
back into p6HRT and transformed into E. coli strain M15, harboring 
lac repressor plasmid pDMI.1 [18]. For heterodimeric enzyme pro- 
duction, these constructs were cut with EcoRV and SalI, and the 
resulting 1.3 kb fragment was ligated into vector p6HRT-PROT [16], 
followed by transformation into E. coli strain Ml5 : pDMI.1. 
2.2. Expression and purification of p66 and p66/5’1 RT 
Two liter L-broth cultures of recombinant strains were grown to 
0D6~ = 0.6 and RT expression was induced by addition of IPTG to 
a final concentration of 400 mg/l. After 4 h, cells were harvested and 
lysed at 4°C in 50 mM NaHrP04-Na2HP04 (pH 7.8), 1 mM PMSF, 
1 mg/ml lysozyme (20 min with stirring). NaCl was added to an end 
concentration of 300 mM and cells were sonicated for 3 x 30 s at 
300 W, using a Labsonic sonicator with a 4 mm microtip (B. Braun). 
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After centrifugation (30 min at 100000 x g, 4”C), the supernatant 
was loaded onto a 2 ml NiZf NTA column [19] equilibrated with at 
least 10 column-vols lysis buffer + 300 mM NaCl. The column was 
washed with 200 mM NH4Ac (pH 6.5), 300 mM NaCI, and 10% 
glycerol until a stable 280 nm baseline was obtained. The hexa- 
histidine tagged enzymes were eluted from the column with a pH gra- 
dient (pH 6.5-4.0) in the same buffer. Fractions (1 ml) were im- 
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mediately neutralized with 0.5 vols of 1 M Tris-HCl (pH 8.2), 
300 mM NaCl, and 10% glycerol. The protein concentration of pool- 
ed fractions was determined using the Biorad protein assay and the 
purity of the enzymes was checked on a 10% SDS-polyacrylamide gel 
(see fig.2). Pooled samples were adjusted to 50% glycerol and stored 
at - 20°C. The overall yield of RT varied between 3 and 10 mg per 
liter of culture. 
2.3. RT- and RNase H filter assay 
Reverse transcription reactions were performed as described 
previously [16] using poly(rC) : oligo(dG) as substrate. 
For the RNase H-activity assay, the DNA-RNA hybrid was 
prepared by unspecific transcription of M13mp18 ssDNA with E. coli 
RNA polymerase in 40 mM Tris-HCl (pH 7.9). 10 mM MgC12, 
150 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 250rM ATP, CTP, 
GTP, 100 pM UTP, and 50 pM [‘5S]UTP (800 Ci/mmol) at 37°C for 
60 min. Unincorporated nucleotides were removed by Sephadex G-25 
gel filtration. RNase H reactions were performed at 37°C in 50 mM 
Tris-HCI (pH 8). 5 mM DTT, 50 mM KC1 and 8 mM MgClz, in the 
presence of 50000 cpm of DNA-RNA hybrid. The different enzyme 
preparations were added at a concentration of 2.5 pg/ml. At times in- 
dicated in fig.3B, 10 pl aliquots were spotted on DEAE filter papers 
(Whatman DE 81) and dried. The filters were washed 3 x 10 min in 
1 x SSC (0.15 M NaCI, 0.015 M Naj-citrate, pH 7.6), 2 x 10 min in 
96% EtOH, and dried. The amount of RNA remaining on the filters 
was determined by scintillation counting. 
2.4. In situ RNase H-activity assay 
In situ gel assays were performed essentially as described earlier [5]. 
For the in situ gel assay [cu-32P]UTP-labelled DNA-RNA hybrid was 
used. Samples containing 2 pg of monomeric or 4 pg of heterodimeric 
RT were loaded on a 10% SDS-polyacrylamide gel containing 
6 x lo6 cpm of DNA-RNA hybrid. After electrophoresis, the en- 
zymes were renatured by washing 3 x 20 min in 50 mM Tris-HCl (pH 
7.8), and 3 mM/3-mercaptoethanol at 37°C. The enzyme reaction was 
performed in 50 mM Tris-HCl (pH 8), 2 mM MnClz, 2 mM DTT, 
and 50 mM NaCl at 37°C for 2 h, with three changes of buffer. The 
gel was stained in Coomassie blue (0.2%), 10% acetic acid, and 50% 
methanol for 30 min, destained in 5% methanol, and 4.2% acetic 
acid, dried and exposed on Kodak X-AR 5 film. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the positions of the mutations introduc- 
ed into the RNase H domain of HIV-l RT. Amino acids 
Fig. 1. Amino acid sequence of HIV-l RT. Residues in the RNase H 
domain that are conserved between several retroviral RNase H do- 
mains and E. co/i RNase H [6] are shown in bold face. Amino acids 
that were mutated are boxed. 
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Fig.2. Mutant and wt RT enzymes after Ni2+ NTA chromatography 
of the crude lysate. Lanes M, mol. wt markers; lanes C 66 and C 
66/5 1, wt homodimeric and heterodimeric RT, respectively. Lanes 66 
and 66/5 1 marked E478 + Q478, homo- and heterodimeric E + Q RT 
mutant; lanes 66/51 and 66 marked H539 + F539, hetero- and homo- 
dimeric H + F mutant RT. 1 (2) yg of homodimeric (heterodimeric) 
RTs were loaded onto the gel. 
shown in bold face are conserved between most retro- 
viral RNase H domains and E. coli RNase H [6]. The 
E 478 + Q and H539 -+ F mutations were chosen because 
they: (i) affect highly conserved amino acid residues; (ii) 
are located at helix-sheet ransitions that are spatially 
clustered as evident from a preliminary three- 
dimensional structure of E. coli RNase H (Morikawa, 
A 
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Fig.3A. RT activity filter assay of mutant and wt enzymes. Incorpora- 
tion of [cu-35S]dGTP was determined in duplicate for five successive 
twofold dilutions of enzyme. Values within linearity were used for the 
computation of specific activities (displayed as bars on log scale). 
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Fig.3B. RNase H activity filter assay of mutant and wt enzymes. The graphs show the loss of radioactivity from the DNA-RNA hybrid with time 
for mutant and wt RTs (as indexed in the figure). DNA-RNA hybrid was incubated at 37°C together with 125 ng (- 1 pmol) of RT-RNase H. At 
the time points indicated, aliquots were withdrawn and spotted on a Whatman DE 81 filter. After several washings, the residual radioactivity on 
the filters was determined by scintillation counting. 
personal communication); and (iii) should not impair 
correct folding of the protein as predicted by the Chou- 
Fasman [20] or Delphi [21] algorithms. In fact, the 
band pattern of peptides produced by partial hydrolysis 
with three different proteases of wild-type (wt) and mu- 
tant RTs on immunoblots stained with polyclonal (w-RT 
antibodies is practically identical (T. Naas, personal 
communication). This may be regarded as indirect 
evidence against a major distortion of the protein’s ter- 
tiary structure, a problem frequently encountered with 
linker insertion mutants. The substitutions constructed 
by oligonucleotide directed mutagenesis in Ml3 as 
described in section 2 were re-cloned either into the 
p6HRT expression vector to produce a p66 homodimer 
RT or into the p6HRT-PROT expression vector con- 
taining a functional HIV-l protease cassette. In the 
latter case, proteolytic processing of the p66 
homodimer generates a p66/51 heterodimer RT which 
is the form found in virions [22]. Bacteria transformed 
with these constructs were grown in parallel and the ex- 
pression of RT was induced by addition of IPTG. 
Overexpressed wt and mutant RTs were purified on 
Ni2+ NTA columns under native conditions (see section 
2). The material recovered is greater than 90% pure (as 
judged from the Coomassie-stained SDS gel shown in 
fig.2). 
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Fig.4. In situ gel analysis of mutant and wt enzymes. Mutant and wt 
polypeptides were separated on a SDS-polyacrylamide gel containing 
32P-DNA-RNA hybrid. After electrophoresis the proteins were 
renatured by removing the SDS. RNase H cleavage is induced by addi- 
tion of Mn2+, after which the gel is fixed, stained and autoradio- 
graphed. The zones of RNase H activity appear as translucent bands 
on a dark background of undigested DNA-RNA hybrid. 
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In order to ascertain that the mutations chosen af- 
fected only RNase H activity, mutant and wt RTs were 
tested for their RT activity by measuring the amount of 
[a-3sS]dGTP incorporated into a poly(rC) : oligo(dG) 
hybrid. In this assay, the mutant 66/51 RTs 
reproducibly perform as well or even better than the wt 
enzyme (fig.3A). On the other hand, the mutant p66 
homodimers (66 H + F, 66 E -+ Q) containing the 
mutations on both polypeptide chains display a reduced 
RT activity. In numerous RT assays, we have observed 
that heterodimeric p66/51 RT is consistently 2-5 times 
more active than the p66 form. The ~51 form of RT 
alone, however, is almost devoid of RT activity ([9] and 
our unpublished results). The proper conformation of 
the enzyme thus seems to be dependent on the presence 
of at least part of the C-terminal RNase H domain. In- 
terestingly, this asymmetric onfiguration is also found 
in other retroviral polymerases [15]. 
Next, we compared the RNase H activity of our 
mutants and wt RT species. As can be seen in fig.3B, 
both wt forms of RT released about the same amount of 
radioactivity (-60-70% of the input RNA-DNA 
hybrid) with almost identical kinetics. On the other 
hand, the 66/5 1 H -+ F mutant shows markedly reduced 
activity, liberating only 35% of the input radioactivity 
with a much slower kinetic. In the 66/51 E + Q mutant, 
RNase H activity is almost totally abolished (less than 
3% release of radioactivity). This would imply that 
Cil~~‘~ plays a very important role in RNase H function. 
To ensure that the RNase H activities measured are 
indeed properties of the p66 (p66/51) RTs (and do not 
result from E. coli RNase H contamination), we have 
performed an RNase H in situ gel analysis (fig.4). 
RNase H activity can only be detected in the p66 species 
of RT, again demonstrating that it resides in the C- 
terminal part. The very light bands that can be seen 
around the position of p5 1 (in the lanes denoted 6615 1) 
are most likely due to quenching and do not represent 
true RNase H activity, since a similar effect is also seen 
with BSA (not shown). 
In conclusion, we have identified two amino acids in 
the C-terminal part of HIV-l RT that are likely to be 
components of the active site of RNase H. Of course, 
definite proof of this concept requires further ex- 
periments. These mutants are now being used for map- 
ping the binding region of the enzyme to a DNA-RNA 
substrate, which so far has been hampered by the 
RNase H cleavage of the RNA. 
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